Laboratorio de Inmunobiología y Diagnóstico Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo de los Bravo 39086, Mexico.
Unidad de Investigación en Inmunología y Proteómica, Laboratorio de Investigación en COVID-19, Hospital Infantil de México "Federico Gómez", Mexico City 06720, Mexico.
Viruses. 2023 Apr 14;15(4):966. doi: 10.3390/v15040966.
COVID-19 vaccination or natural infection is associated with the development of immunity. The search of IgA and IgG antibodies against all the structural proteins (spike, nucleocapsid, membrane, and envelope) of SARS-CoV-2 in breastfeeding mothers is associated with immunity that can help the newborn avoid development of the infection. In this study, we analyzed 30 breastfeeding women that provided samples of breast milk and serum and evaluated the presence of IgA, total IgG, and subclasses against the structural proteins of SARS-CoV-2. We reported a high seroprevalence to IgA (76.67-100%) and negativity to IgG against all analyzed proteins in breast milk. Seroprevalence in serum samples was around 10-36.67% to IgA and 23.3-60% to IgG. Finally, we detected the presence of the subclasses IgG1, IgG2, and IgG4 against all the structural proteins of SARS-CoV-2. This work provides evidence of the presence of IgA and IgG antibodies against the four structural proteins of SARS-CoV-2 in breast milk and serum samples derived from breastfeeding women, which can confer immunity to the newborn.
COVID-19 疫苗接种或自然感染会引发免疫反应。对 SARS-CoV-2 的所有结构蛋白(刺突蛋白、核衣壳蛋白、膜蛋白和包膜蛋白)的 IgA 和 IgG 抗体的检测与能够帮助新生儿避免感染的免疫反应有关。在这项研究中,我们分析了 30 位提供母乳和血清样本的哺乳期妇女,评估了针对 SARS-CoV-2 结构蛋白的 IgA、总 IgG 和亚类的存在情况。我们报告了针对 IgA 的高血清阳性率(76.67-100%)和针对所有分析的乳蛋白 IgG 的阴性。血清样本中针对 IgA 的血清阳性率约为 10-36.67%,针对 IgG 的血清阳性率约为 23.3-60%。最后,我们检测到针对 SARS-CoV-2 的所有结构蛋白的 IgG1、IgG2 和 IgG4 亚类的存在。这项工作提供了证据表明,针对 SARS-CoV-2 的四个结构蛋白的 IgA 和 IgG 抗体存在于来自哺乳期妇女的母乳和血清样本中,这可以为新生儿提供免疫力。
Int J Environ Res Public Health. 2021-8-21
J Pediatric Infect Dis Soc. 2022-4-30
Pediatrics. 2021-11
Indian J Med Res. 2024-11
Vaccines (Basel). 2022-1-16
Biomolecules. 2021-11-23